NRX Pharmaceuticals, Inc. - NRXP
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 10
Latest filed: Jun 04, 2026
| Form | Count |
|---|---|
| 8-K | 8 |
| SCHEDULE 13G/A | 1 |
| 4 | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jun 04, 2026 | 8-K | Jun 03, 2026 | 0001437749-26-019576 | View |
| Jun 02, 2026 | 8-K | Jun 02, 2026 | 0001437749-26-019196 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001193125-26-225997 | View |
| Mar 24, 2026 | 8-K | Mar 23, 2026 | 0001437749-26-009611 | View |
| Feb 17, 2026 | 8-K | Feb 17, 2026 | 0001437749-26-004245 | View |
| Feb 17, 2026 | 8-K | Feb 17, 2026 | 0001437749-26-004246 | View |
| Feb 17, 2026 | 4 | Jan 27, 2026 | 0001437749-26-004426 | View |
| Feb 02, 2026 | 8-K | Jan 27, 2026 | 0001437749-26-002682 | View |
| Jan 16, 2026 | 8-K | Jan 12, 2026 | 0001437749-26-001455 | View |
| Dec 29, 2025 | 8-K | Dec 18, 2025 | 0001437749-25-038835 | View |